Xeris Biopharma Holdings, Inc. - Common Stock (XERS)

Xeris Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for patients with chronic diseases and conditions

Utilizing its proprietary technology platforms, the company aims to enhance the delivery of injectable medications, creating formulations that are designed to be more convenient and effective for patients. Xeris is dedicated to addressing unmet medical needs by bringing forward products that can improve treatment experiences and outcomes for individuals with conditions such as diabetes and other specialty therapy needs.